J.E. Schopman

789 total citations
11 papers, 567 citations indexed

About

J.E. Schopman is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Neurology. According to data from OpenAlex, J.E. Schopman has authored 11 papers receiving a total of 567 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Endocrinology, Diabetes and Metabolism, 3 papers in Surgery and 3 papers in Neurology. Recurrent topics in J.E. Schopman's work include Diabetes Management and Research (6 papers), Diabetes Treatment and Management (4 papers) and Pancreatic function and diabetes (3 papers). J.E. Schopman is often cited by papers focused on Diabetes Management and Research (6 papers), Diabetes Treatment and Management (4 papers) and Pancreatic function and diabetes (3 papers). J.E. Schopman collaborates with scholars based in Netherlands, United Kingdom and Denmark. J.E. Schopman's co-authors include J. Geddes, Brian M. Frier, Nicola N. Zammitt, F. Holleman, J. B. L. Hoekstra, R. J. P. M. Scholten, B M Frier, Max Nieuwdorp, Anne Vrieze and Wanda M. Admiraal and has published in prestigious journals such as Metabolism, Journal of Nuclear Medicine and Diabetic Medicine.

In The Last Decade

J.E. Schopman

11 papers receiving 553 citations

Peers

J.E. Schopman

EDM

GENET

SURGE

PHYSI

CCM

G. Rayman United Kingdom

Manuel Dolz France

Nino G. Joy United States

Tetsuyuki Yasuda Japan

Jeanne Hejna United States

Ylva Wessman Sweden

Piotr Molęda Poland

H. J. Gjessing Denmark

J. A. Torrens United Kingdom

Jun Inaishi Japan

G. Rayman United Kingdom

J.E. Schopman

253 ×0.5

EDM

74 ×0.3

GENET

128 ×0.5

SURGE

49 ×0.7

PHYSI

24 ×0.6

CCM

Citations per year, relative to J.E. Schopman J.E. Schopman (= 1×) peers G. Rayman

Countries citing papers authored by J.E. Schopman

Since Specialization

Citations

This map shows the geographic impact of J.E. Schopman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.E. Schopman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.E. Schopman more than expected).

Fields of papers citing papers by J.E. Schopman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.E. Schopman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.E. Schopman. The network helps show where J.E. Schopman may publish in the future.

Co-authorship network of co-authors of J.E. Schopman

This figure shows the co-authorship network connecting the top 25 collaborators of J.E. Schopman. A scholar is included among the top collaborators of J.E. Schopman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.E. Schopman. J.E. Schopman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Schopman, J.E., et al.. (2025). Efficacy and Toxicity of Bevacizumab in Children with NF2-Related Schwannomatosis: A Systematic Review. Cancers. 17(3). 519–519. 1 indexed citations

Hensen, Erik F., et al.. (2024). Bevacizumab Treatment for Patients with NF2-Related Schwannomatosis: A Single Center Experience. Cancers. 16(8). 1479–1479. 3 indexed citations

Heidsma, Charlotte M., et al.. (2021). Health‐related quality of life and treatment effects in patients with well‐differentiated gastroenteropancreatic neuroendocrine neoplasms: A systematic review and meta‐analysis. European Journal of Cancer Care. 30(6). e13504–e13504. 5 indexed citations

Schopman, J.E., J. B. L. Hoekstra, Brian M. Frier, et al.. (2015). Effects of sitagliptin on counter‐regulatory and incretin hormones during acute hypoglycaemia in patients with type 1 diabetes: a randomized double‐blind placebo‐controlled crossover study. Diabetes Obesity and Metabolism. 17(6). 546–553. 16 indexed citations

Schopman, J.E., Wanda M. Admiraal, Maarten R. Soeters, et al.. (2014). 18F-fluorodeoxyglucose uptake in brown adipose tissue during insulin-induced hypoglycemia and mild cold exposure in non-diabetic adults. Metabolism. 63(10). 1280–1286. 6 indexed citations

Schopman, J.E., J. B. L. Hoekstra, Ameen Abu‐Hanna, et al.. (2014). Factors that drive insulin‐dosing decisions of diabetes care providers: a vignette‐based study in the Netherlands. Diabetic Medicine. 32(1). 69–77. 3 indexed citations

Schopman, J.E., et al.. (2013). The incidence of mild and severe hypoglycaemia in patients with type 2 diabetes mellitus treated with sulfonylureas: a systematic review and meta‐analysis. Diabetes/Metabolism Research and Reviews. 30(1). 11–22. 92 indexed citations

Vrieze, Anne, J.E. Schopman, Wanda M. Admiraal, et al.. (2012). Fasting and Postprandial Activity of Brown Adipose Tissue in Healthy Men. Journal of Nuclear Medicine. 53(9). 1407–1410. 46 indexed citations

Schopman, J.E., J. Geddes, & B M Frier. (2010). Frequency of symptomatic and asymptomatic hypoglycaemia in Type 1 diabetes: effect of impaired awareness of hypoglycaemia. Diabetic Medicine. 28(3). 352–355. 30 indexed citations

10.

Schopman, J.E., J. Geddes, & Brian M. Frier. (2009). Prevalence of impaired awareness of hypoglycaemia and frequency of hypoglycaemia in insulin-treated Type 2 diabetes. Diabetes Research and Clinical Practice. 87(1). 64–68. 96 indexed citations

11.

Geddes, J., J.E. Schopman, Nicola N. Zammitt, & Brian M. Frier. (2008). Prevalence of impaired awareness of hypoglycaemia in adults with Type 1 diabetes. Diabetic Medicine. 25(4). 501–504. 269 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact